What we do
Plain Decisions is an independent health information resource focused on weight loss treatments. We compare FDA-approved medications, clinical trial data, costs, and side effects so you can make informed decisions with your doctor.
We cover 7 approved medications, 4 pipeline treatments, 25 supplements, and reference over 50 published clinical trials. Every factual claim on this site links back to its source study.
We do not sell medications, accept advertising, or receive compensation from pharmaceutical companies. We have no financial relationship with any drug manufacturer.
Our editorial standards
Evidence-based only
Every treatment claim is supported by published clinical trial data. We cite the specific trial name, sample size, duration, and results. When data is limited or conflicting, we say so explicitly.
No recommendations or rankings
We present trial data and let you decide with your healthcare provider. We never say one drug is "better" than another, never rank treatments, and never suggest what you should take. Treatment decisions depend on your individual health profile, and that requires a doctor.
Plain language first
Our audience is everyday people, not medical professionals. We use clear, conversational language. When medical terminology is necessary, we explain it. Content is written at a reading level accessible to most adults.
Trial language standards
We always say "In clinical trials, participants lost..." or "Trial data suggests..." rather than "You will lose..." We frame weight loss data as averages from study populations, not individual predictions.
Regular review cycle
Pages are reviewed and updated as new trial data is published or drug approvals change. Each page shows its last review date. Pricing data is verified quarterly. Pipeline drug timelines are updated when FDA milestones occur.
How we source information
Our primary sources are peer-reviewed clinical trials published in journals including The New England Journal of Medicine, The Lancet, JAMA, and Obesity. We also reference FDA approval documents, prescribing information, and manufacturer-published pricing.
For pricing information, we use publicly available list prices from manufacturer websites, pharmacy benefit managers, and CMS data. We note that actual out-of-pocket costs vary by insurance, location, and savings programs.
We do not cite news articles, social media, or anecdotal reports as primary sources for treatment efficacy claims. When we reference these sources for context (like drug approval timelines), we label them clearly.
Pipeline drug policy
For drugs not yet approved by the FDA, we always include clear caveats about their status. Phase II and Phase III trial results are presented with explicit notes that these drugs are not yet available, timelines are estimates, and final approved formulations may differ from trial versions. We never present pipeline data as if the drug were currently available.
Contact
If you find an error, have a question about our sourcing, or want to suggest a topic, reach us at hello@plaindecisions.com.
Next step most people take
Backed by evidence · Every claim linked to its source
Last reviewed: April 2026